Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Possible Role of Matrix Metalloproteinase in Osteolytic Intracranial Meningiomas

  • Moon, Hyung-Sik (Department of Neurosurgery, Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School) ;
  • Jung, Shin (Department of Neurosurgery, Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School) ;
  • Jung, Tae-Young (Department of Neurosurgery, Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School) ;
  • Cao, Van Thang (Brain Tumor Research Laboratory, Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School) ;
  • Moon, Kyung-Sub (Department of Neurosurgery, Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School) ;
  • Kim, In-Young (Department of Neurosurgery, Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital & Medical School)
  • Published : 2010.01.28
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: Abnormalities of the bone are frequently encountered in patients with meningioma, and hyperostosis and endostosis are common bone alterations in these tumors. Extensive bony destruction is very unusual in patients with meningioma. We report six cases of intracranial meningioma associated with an osteolytic lesion of the skull and discuss the underlying mechanisms that may be responsible for bone destruction in patients with meningioma. Methods: Six patients were classified into three groups, severe, moderate and mild, according to the degree of osteolytic bony destruction. The tumor was classified as intracranial or extracranial, depending on its location. We investigated the potential role of matrix metalloproteinase (MMP) in meningioma-associated osteolysis. The levels of MMP expression were determined by gelatin zymography, reverse transcription-quantitative PCR analysis (RT-PCR) and immunohistochemical analysis. Results: Complete surgical removal of the lesion was performed in each patient. Histological examination revealed benign meningioma in four cases, and two cases of atypical meningioma. Patients did not have a poor prognosis except one case of recurred atypical meningioma. Gelatin zymography and RT-PCR detected high levels of MMP-2 in almost all extracranial masses in comparison with the intracranial masses and MMP9 in two. There was no difference in the severity of bone destruction. Immunohistochemical analysis revealed MMP-2 expression in the vicinity of the bone destruction, and a few MMP-9-positive stainings were observed. Conclusion: Osteolysis of the skull in patients with meningiomas might not be indicative of malignant pathological features and poor prognosis. Invasion to the extracranial portion and osteolysis might be associated with MMP-2 expression in meningioma.

Keywords

References

  1. Baek JU, Cho YD, Yoo JC : An osteolytic meningioma en plaque of the sphenoid ridge. J Korean Neurosurg Soc 43 : 34-36, 2008 https://doi.org/10.3340/jkns.2008.43.1.34
  2. Changhong L, Naiyin C, Yuehuan G, Lianzhong Z : Primary intraosseous meningiomas of the skull. Clin Radiol 52 : 546-549, 1997 https://doi.org/10.1016/S0009-9260(97)80333-9
  3. Coussens LM, Fingleton B, Matrisian LM : Matrix metalloproteinase inhibitors and cancer : trials and tribulations. Science 295 : 2387-2392, 2002 https://doi.org/10.1126/science.1067100
  4. Das A, Tan WL, Smith DR : Expression of extracellular matrix markers in benign meningiomas. Neuropathology 23 : 275-281, 2003 https://doi.org/10.1046/j.1440-1789.2003.00512.x
  5. Doyle WF, Rosegay H : Meningioma en plaque with hyperostosis : case report. Mil Med 137 : 196-198, 1972
  6. Hur JH, Park MJ, Park IC, Yi DH, Rhee CH, Hong SI, et al. : Matrix metalloproteinases in human glioma : activation of matrix metalloproteinase- 2 (MMP-2) may be correlated with membrane-type-1 metrix metalloproteinase (MT1-MMP) expression. J Korean Med Sci 15 : 309-314, 2000
  7. Husaini TA : An unusual osteolytic meningioma. J Pathol 101 : 57-58, 1970 https://doi.org/10.1002/path.1711010107
  8. Johansson N, Ahonen M, Kähäri VM : Matrix metalloproteinases in tumor invastion. Cell Mol Life Sci 57 : 5-15, 2000 https://doi.org/10.1007/s000180050495
  9. Kachra Z, Beaulieu E, Delbecchi L, Mousseau N, Berthelet F, Moumdjian R, et al. : Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin Exp Metastasis 17 : 555-566, 1999 https://doi.org/10.1023/A:1006760632766
  10. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon Cardo C, et al. : A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3 : 537-549, 2003 https://doi.org/10.1016/S1535-6108(03)00132-6
  11. Kashimura H, Beppu T, Wada T, Yoshida Y, Suzuki M, Ogawa A : [A case of meningioma en plaque : review of 73 cases.] No Shinkei Geka 25 : 1097-1100, 1997
  12. Mozoue T, Kawamoto H, Arita K, Tominaga A, Kurisu K : Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase- 1 by meningiomas detected by cell immuoblot analysis. Acta Neurochir (Wien) 141 : 481-486, 1999 https://doi.org/10.1007/s007010050328
  13. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, et al. : Production of metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81 : 69-77, 1994 https://doi.org/10.3171/jns.1994.81.1.0069
  14. Nordqvist AC, Smurawa H, Mathiesen T : Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. J Neurosurg 95 : 839-844, 2001 https://doi.org/10.3171/jns.2001.95.5.0839
  15. Okada M, Miyake K, Matsumoto Y, Kawai N, Kunishio K, Nagao S : Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas. J Neurooncol 66 : 29-37, 2004
  16. Olmsted WW, McGee TP : Prognosis in meningioma through evaluation of skull bone patterns. Radiology 123 : 375-377, 1977
  17. Perret AG, Duthel R, Fotso MJ, Brunon J, Mosnier JF : Stromelysin-3 is expressed by aggressive meningiomas. Cancer 94 : 765-772, 2002 https://doi.org/10.1002/cncr.10270
  18. Rooprai H, McCormick D : Proteases and their inhibitors in human brain tumors : a review. Anticancer Res 17 : 4151-4162, 1997
  19. Rooprai HK, van Meter TE, Robinson SD, King A, Rucklidge GJ, Pilkington GJ : Expression of MMP-2 and -9 in short-term cultures of meningioma : influence of histological subtype. Int J Mol Med 12 : 977-981, 2003
  20. Russel DS, Rubinstein LJ : Pathology of Tumours of the Nervous System, ed 2. Baltimore : Williams & Wilkins, 1989, pp449-532
  21. Steeg PS : Tumor metastasis : mechanistic insights and clinical challenges. Nat Med 12 : 895-904, 2006 https://doi.org/10.1038/nm1469
  22. Taveras JM, Wood EH : Diagnostic Neuroradiology. Baltimore : Williams & Wilkins, 1964, pp 153-182
  23. Uhm JH, Dooley NP, Villemure JG, Yong VW : Mechanisms of glioma invasion : role of matrix-metalloproteinases. Can J Neurol Sci 24 : 3-15, 1997
  24. Winding, B, NicAmhlaobh R, Misander H, Hoegh-Andersen P, Andersen TL, Holst-Hansen C, et al. : Synthetic matrix metalloproteinase inhibitor inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice. Clin Cancer Res 8 : 1932-1939, 2002
  25. Younis G, Sawaya R : Intracranial osteolytic malignant meningiomas appearing as extracranial soft-tissue masses. Neurosurgery 30 : 932-935, 1992 https://doi.org/10.1227/00006123-199206000-00022

Cited by

  1. Feline intracranial meningioma with skull erosion and tumour extension into an area of skull hyperostosis vol.13, pp.4, 2011, https://doi.org/10.1016/j.jfms.2011.01.006
  2. Extracranial expansion of a feline meningioma vol.15, pp.8, 2010, https://doi.org/10.1177/1098612x12472175
  3. Proteins involved in regulating bone invasion in skull base meningiomas vol.155, pp.3, 2010, https://doi.org/10.1007/s00701-012-1577-9
  4. Progression of Intracranial Meningioma during Luteinizing Hormone-Releasing Hormone Agonist Treatment for Prostate Cancer: Case Report vol.54, pp.4, 2010, https://doi.org/10.2176/nmc.cr2012-0417
  5. Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas vol.24, pp.22, 2010, https://doi.org/10.1158/1078-0432.ccr-18-0472
  6. Multimodality characteristics of multifocal choroid plexus carcinoma with bilateral calvarial defects in a dog vol.62, pp.3, 2021, https://doi.org/10.1111/vru.12732
  7. Expression of IL-6 and matrix metalloproteinases in a convexity meningiomas with hyperostosis: Case report vol.27, pp.None, 2010, https://doi.org/10.1016/j.inat.2021.101374